SAN DIEGO, Aug. 14, 2019 — Medical Marijuana, Inc. (OTC:MJNA) (“the Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® will be attending and exhibiting at SuperZoo, the most-attended pet industry show in North America, in Las Vegas on Aug. 20-22.
At the conference, HempMeds® will unveil its new cannabidiol (CBD) pet product line, Hemp for Pets by HempMeds®, made with the Company’s Triple Lab Tested™ full-spectrum hemp oil and THC-free isolate. The Brightfield Group recently reported that the U.S. CBD pet product market was worth $32 million in 2018 and is estimated to grow to at least $1.16 billion by 2022.
“I consider myself lucky to have spent multiple years in leadership in the pet industry prior to becoming President of HempMeds. There are few industries that are as passionate and committed to providing the best care possible to their loved ones,” said HempMeds® President Todd Morrow. “Being a pet lover myself, it just made sense to capitalize on our innovation, quality, standards and testing we require of all our products for people and applying that capability to improving pets’ lives. I know pet parents, rescues, shelters and the pet industry as a whole share the same desire to help improve pets’ lives and they need to have confidence they’re getting the same commitment to quality as our human customers expect. Behaviorally, socially, and physically, Hemp for Pets by HempMeds was developed with a dedication to providing the highest quality and most powerful hemp solutions to make a positive difference in pets’ lives.”
SuperZoo was established by the World Pet Association in 1950 as an annual gathering place for the entire pet product industry to connect, learn and do business. The show has continued to grow for the past 69 years and now boasts more buyers and education hours than any other industry event on the continent. With its diverse education offerings and easy-to-shop show floor, SuperZoo has earned its reputation as North America’s premier pet retail event. In 2018, SuperZoo hosted almost 10,000 attendees and 1,200 exhibitors.
“As shown by the $33 billion Americans spent on pet food and treats in 2018, it’s obvious that the pet product market is not slowing down,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “For over a decade our Company has offered the many potential benefits of CBD to humans around the world and we look forward to providing them to our customers’ pets as well.”
HempMeds® was the first company to ever bring hemp-based CBD oil products to market in the U.S. in 2012 and was the first to both make CBD products available in bulk for U.S. consumers. HempMeds® was also the first-ever company to receive historic federal government import approvals for its CBD products in the nations of Argentina, Brazil, Mexico and Paraguay, as well as the first to have CBD products listed in the Prescribers Digital Reference and one of the first to be certified by the U.S. Hemp Authority.
Visit booth #6261 to learn more about these products. Please contact email@example.com to schedule any onsite interviews.
For more information about HempMeds®, please visit www.hempmedspx.com.
About Medical Marijuana, Inc.
We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its internal R&D and scientific team and its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer CMW Media
Investor Relations Contact:
P. (858) 283-4016